Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural insights into clonal restriction and diversity in T cell recognition of two immunodominant SARS-CoV-2 nucleocapsid epitopes.

Nature communications·2025
Same author

Structural characterization and AlphaFold modeling of human T cell receptor recognition of NRAS cancer neoantigens.

Science advances·2024
Same author

SARS-CoV-2 infection establishes a stable and age-independent CD8<sup>+</sup> T cell response against a dominant nucleocapsid epitope using restricted T cell receptors.

Nature communications·2023
Same author

Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.

Nature communications·2022
Same author

FGFR-TKI resistance in cancer: current status and perspectives.

Journal of hematology & oncology·2021
Same author

Huang Qi Decoction Prevents BDL-Induced Liver Fibrosis Through Inhibition of Notch Signaling Activation.

The American journal of Chinese medicine·2017

Related Experiment Video

Updated: Jun 11, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.4K

Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy.

Zhouchi Yao1, Yayun Zeng2, Cheng Liu1

  • 1Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital, Laboratory of Structural Immunology, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.

Journal of Experimental & Clinical Cancer Research : CR
|September 28, 2024
PubMed
Summary

Enhancing CD8+ T cell function is key to fighting solid tumors. This review explores new strategies to boost T cell receptor (TCR) signaling, antigen recognition, tumor homing, and metabolic pathways for improved anti-tumor immunity.

Keywords:
CD8+ T cellEngineered T cell receptor -T cellsGene editingImmune checkpointImmune reprogrammingImmunotherapyMetabolic reprogrammingSolid tumorT cell redirection

More Related Videos

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.6K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

300

Related Experiment Videos

Last Updated: Jun 11, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.4K
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.6K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

300

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • CD8+ T cells are critical for anti-tumor immunity against solid tumors.
  • Understanding T cell activity and lifespan is vital for effective cancer immunotherapy.

Purpose of the Study:

  • To review novel strategies for enhancing CD8+ T cell function against solid tumors.
  • To highlight methods for optimizing T cell receptor (TCR) expression and antigen recognition.
  • To discuss approaches for improving T cell persistence and effectiveness in the tumor microenvironment.

Main Methods:

  • Review of recent advances in T cell engineering and immunotherapy.
  • Focus on optimizing TCR signaling, antigen recognition, and T cell homing.
  • Exploration of strategies to reverse T cell exhaustion and reprogram T cell metabolism.
  • Discussion of epigenetic modifications influencing T cell anti-tumor responses.

Main Results:

  • Optimizing TCR expression and antigen recognition can enhance T cell targeting of tumors.
  • Improving T cell homing and reversing exhaustion are crucial for sustained anti-tumor activity.
  • Reprogramming T cell metabolism and epigenetic landscape can boost effectiveness and persistence.
  • Recent advances offer promising avenues for next-generation cancer immunotherapies.

Conclusions:

  • Multiple strategies exist to enhance CD8+ T cell-mediated anti-tumor immunity.
  • Targeting TCR signaling, metabolism, and epigenetics holds significant potential for cancer immunotherapy.
  • Further research into these areas will guide the development of more effective treatments for solid tumors.